However, the United States is currently not on track, bogged down by litigation over warnings on cigarette packaging and lags in taxation, said Vinayak Prasad of the WHO’s tobacco control unit.

Vinayak Prasad, programme manager of WHO's tobacco control unit, told reporters that development of new products was solely intended to expand the markets of tobacco firms.

"We are asking for guidance to help the FDA decide what strain to select for COVID-19 vaccines going forward," the Center for Biologics Evaluation and Research director Dr. Vinayak Prasad said at ...

Prasad and Makary praised the initial Covid-19 vaccine rollout as "a major scientific, medical, and regulatory accomplishment," but argued that the benefits of repeated boosters for low-risk ...

On the C-SPAN Networks: Vinayak Prasad M.D. is a Professor for Medicine in the University of California, San Francisco with one video in the C-SPAN Video Library; the first appearance was a 2022 ...

About The Article: This Viewpoint, by Vinay Prasad, MD, MPH, of the Center for Biologics Evaluation and Research, Food and Drug Administration, and colleagues discusses a safety communication ...

The United States will limit Covid-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine makers to run fresh clinical trials before offering shots ...

But Makary and Prasad pushed back on that comparison, arguing the genetic changes in Covid variants haven’t been significant enough to justify automatically updating the vaccine each year.